An FDA-approved clinical trial is being conducted to test whether a non-invasive technology safely and effectively reduces pain from bone metastases. This outpatient procedure destroys the pain-causing nerves in the bone surface surrounding the tumor to relieve pain. 
This non-invasive technology is called Magnetic Resonance guided Focused Ultrasound (MRgFUS), and is being used on an ExAblate system. 

Download a patient pamphlet about the WIRB approved trial (PDF 300KB).
Watch a featured video about the treatment with ExAblate for uterine fibroids and pain palliation of bone metastases (Madison - MedStar, WKOWTV.com).